Publications search

Found 37769 matches. Displaying 9911-9920
Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BYT
Show All Authors

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

CLINICAL INFECTIOUS DISEASES 2010 FEB 15; 50(4):605-612
BENCHMRK-1 and -2 are ongoing double-blind phase III studies of raltegravir in patients experiencing failure of antiretroviral therapy with triple-class drug-resistant human immunodeficiency virus infection. At week 96 (combined data), raltegravir (400 mg twice daily) plus optimized background therapy was generally well tolerated, with superior and durable antiretroviral and immunological efficacy, compared with optimized background therapy alone.
McEwen BS, Wingfield JC
Show All Authors

What is in a name? Integrating homeostasis, allostasis and stress

HORMONES AND BEHAVIOR 2010 FEB; 57(2):105-111
Aaltonen T, Adelman J, Gonzalez BA, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Apresyan A, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Attal A, Aurisano A, Azfar F, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauer G, Beauchemin PH, Bedeschi F, Beecher D, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Calancha C, Camarda S, Campanelli M, Campbell M, Canelli F, Canepa A, Carls B, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chung K, Chung WH, Chung YS, Chwalek T, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Crescioli F, Almenar CC, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lorenzo G, Dell'Orso M, Deluca C, Demortier L, Deng J, Deninno M, d'Errico M, Di Canto A, di Giovanni GP, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Dorigo T, Dube S, Ebina K, Elagin A, Erbacher R, Errede D, Errede S, Ershaidat N, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Frank MJ, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Garosi P, Genser K, Gerberich H, Gerdes D, Gessler A, Giagu S, Giakoumopoulou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, Gonzalez O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Group RC, Grundler U, da Costa JG, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Han BY, Han JY, Happacher F, Hara K, Hare D, Hare M, Harr RF, Hartz M, Hatakeyama K, Hays C, Heck M, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Hurwitz M, Husemann U, Hussein M, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jha MK, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Ketchum W, Keung J, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim HW, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Knuteson B, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kreps M, Kroll J, Krop D, Krumnack N, Kruse M, Krutelyov V, Kuhr T, Kulkarni NP, Kurata M, Kwang S, Laasanen AT, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee E, Lee HS, Lee JS, Lee SW, Leone S, Lewis JD, Lin CJ, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu C, Liu T, Lockyer NS, Loginov A, Lovas L, Lucchesi D, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, MacQueen D, Madrak R, Maeshima K, Makhoul K, Maksimovic P, Malde S, Malik S, Manca G, Manousakis-Katsikakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin V, Martinez M, Martinez-Ballarin R, Mastrandrea P, Mathis M, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzione A, Mesropian C, Miao T, Mietlicki D, Miladinovic N, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Mondragon MN, Moon CS, Moore R, Morello MJ, Morlock J, Fernandez PM, Mulmenstadt J, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakamura K, Nakano I, Napier A, Nett J, Neu C, Neubauer MS, Neubauer S, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oakes L, Oh SH, Oh YD, Oksuzian I, Okusawa T, Orava R, Osterberg K, Griso SP, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramanov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Peiffer T, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Pianori E, Pinera L, Pitts K, Plager C, Pondrom L, Potamianos K, Poukhov O, Prokoshin F, Pronko A, Ptohos F, Pueschel E, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Renton P, Renz M, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rodriguez T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Rutherford B, Saarikko H, Safonov A, Sakumoto WK, Santi L, Sartori L, Sato K, Savoy-Navarro A, Schlabach P, Schmidt A, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sforza F, Sfyrla A, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shiraishi S, Shochet M, Shon Y, Shreyber I, Simonenko A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soha A, Somalwar S, Sorin V, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Strycker GL, Suh JS, Sukhanov A, Suslov I, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tang J, Tecchio M, Teng PK, Thom J, Thome J, Thompson GA, Thomson E, Tipton P, Ttito-Guzman P, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Tourneur S, Trovato M, Tsai SY, Tu Y, Turini N, Ukegawa F, Uozumi S, van Remortel N, Varganov A, Vataga E, Vazquez F, Velev G, Vellidis C, Vidal M, Vila I, Vilar R, Vogel M, Volobouev I, Volpi G, Wagner P, Wagner RG, Wagner RL, Wagner W, Wagner-Kuhr J, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Weinelt J, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Wilbur S, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wolfe H, Wright T, Wu X, Wurthwein F, Xie S, Yagil A, Yamamoto K, Yamaoka J, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanetti A, Zeng Y, Zhang X, Zheng Y, Zucchelli S
Show All Authors

Measurement of the top quark mass in the dilepton channel using m(T2) at CDF

PHYSICAL REVIEW D 2010 FEB 1; 81(3):? Article 031102
We present measurements of the top quark mass using m(T2), a variable related to the transverse mass in events with two missing particles. We use the template method applied to t (t) over bar dilepton events produced in p (p) over bar collisions at Fermilab's Tevatron Collider and collected by the CDF detector. From a data sample corresponding to an integrated luminosity of 3.4 fb(-1), we select 236 t (t) over bar candidate events. Using the m(T2) distribution, we measure the top quark mass to be M-top = 168.0(-4.0)(4.8)(stat) +/- 2.9(syst) GeV/c(2). By combining m(T2) with the reconstructed top quark mass distributions based on a neutrino weighting method, we measure M-top = 169.3 +/- 2.7(stat) +/- 3.2(syst) GeV/c(2). This is the first application of the m(T2) variable in a mass measurement at a hadron collider.
Aaltonen T, Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Adelman J, Aguilo E, Alexeev GD, Alkhazov G, Alton A, Gonzalez BA, Alverson G, Alves GA, Amerio S, Amidei D, Anastassov A, Ancu LS, Annovi A, Antos J, Aoki M, Apollinari G, Appel J, Apresyan A, Arisawa T, Arnoud Y, Arov M, Artikov A, Asaadi J, Ashmanskas W, Askew A, Asman B, Atramentov O, Attal A, Aurisano A, Avila C, Azfar F, BackusMayes J, Badaud F, Badgett W, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barbaro-Galtieri A, Barberis E, Barfuss AF, Baringer P, Barnes VE, Barnett BA, Barreto J, Barria P, Bartlett JF, Bartos P, Bassler U, Bauer D, Bauer G, Beale S, Bean A, Beauchemin PH, Bedeschi F, Beecher D, Begalli M, Begel M, Behari S, Belanger-Champagne C, Bellantoni L, Bellettini G, Bellinger J, Benitez JA, Benjamin D, Beretvas A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besancon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blazey G, Blessing S, Blocker C, Bloom K, Blumenfeld B, Bocci A, Bodek A, Boehnlein A, Boisvert V, Boline D, Bolton TA, Boos EE, Borissov G, Bortoletto D, Bose T, Boudreau J, Boveia A, Brandt A, Brau B, Bridgeman A, Brigliadori L, Brock R, Bromberg C, Brooijmans G, Bross A, Brown D, Brubaker E, Bu XB, Buchholz D, Budagov J, Budd HS, Budd S, Buehler M, Buescher V, Bunichev V, Burdin S, Burkett K, Burnett TH, Busetto G, Bussey P, Buszello CP, Buzatu A, Byrum KL, Cabrera S, Calancha C, Calfayan P, Calpas B, Calvet S, Camacho-Perez E, Camarda S, Cammin J, Campanelli M, Campbell M, Canelli F, Canepa A, Carls B, Carlsmith D, Carosi R, Carrasco-Lizarraga MA, Carrera E, Carrillo S, Carron S, Casal B, Casarsa M, Casey BCK, Castilla-Valdez H, Castro A, Catastini P, Cauz D, Cavaliere V, Cavalli-Sforza M, Cerri A, Cerrito L, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chang SH, Chen YC, Chertok M, Cheu E, Chevalier-Thery S, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Cho DK, Cho SW, Choi S, Chokheli D, Chou JP, Choudhary B, Christoudias T, Chung K, Chung WH, Chung YS, Chwalek T, Cihangir S, Ciobanu CI, Ciocci MA, Claes D, Clark A, Clark D, Clutter J, Compostella G, Convery ME, Conway J, Cooke M, Cooper WE, Corbo M, Corcoran M, Cordelli M, Couderc F, Cousinou MC, Cox CA, Cox DJ, Crescioli F, Almenar CC, Cuevas J, Culbertson R, Cully JC, Cutts D, Cwiok M, Dagenhart D, d'Ascenzo N, Das A, Datta M, Davies G, Davies T, De K, de Barbaro P, De Cecco S, Deisher A, de Jong SJ, De La Cruz-Burelo E, Deliot F, Dell'Orso M, De Lorenzo G, Deluca C, Demarteau M, Demina R, Demortier L, Deng J, Deninno M, Denisov D, Denisov SP, d'Errico M, Desai S, DeVaughan K, Di Canto A, Diehl HT, Diesburg M, Di Ruzza B, Dittmann JR, Dominguez A, Donati S, Dong P, D'Onofrio M, Dorigo T, Dorland T, Dube S, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Ebina K, Edmunds D, Elagin A, Ellison J, Elvira VD, Enari Y, Eno S, Erbacher R, Errede D, Errede S, Ershaidat N, Eusebi R, Evans H, Evdokimov A, Evdokimov VN, Facini G, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Ferapontov AV, Ferbel T, Fernandez JP, Ferrazza C, Fiedler F, Field R, Filthaut F, Fisher W, Fisk HE, Flanagan G, Forrest R, Fortner M, Fox H, Frank MJ, Franklin M, Freeman JC, Fuess S, Furic I, Gadfort T, Galea CF, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garcia-Bellido A, Garfinkel AF, Garosi P, Gavrilov V, Gay P, Geist W, Geng W, Gerbaudo D, Gerber CE, Gerberich H, Gerdes D, Gershtein Y, Gessler A, Giagu S, Giakoumopoulou V, Giannetti P, Gibson K, Gillberg D, Gimmell JL, Ginsburg CM, Ginther G, Giokaris N, Giordani M, Giromini P, Giunta M, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Golovanov G, Gomez B, Gomez G, Gomez-Ceballos G, Goncharov M, Gonzalez O, Gorelov I, Goshaw AT, Goulianos K, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gresele A, Grinstein S, Gris P, Grivaz JF, Grohsjean A, Grosso-Pilcher C, Group RC, Grundler U, Nendahl SG, Grunewald MW, da Costa JG, Gunay-Unalan Z, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Haber C, Haefner P, Hagopian S, Hahn SR, Haley J, Halkiadakis E, Hall I, Han BY, Han JY, Han L, Happacher F, Hara K, Harder K, Hare D, Hare M, Harel A, Harr RF, Hartz M, Hatakeyama K, Hauptman JM, Hays C, Hays J, Hebbeker T, Heck M, Hedin D, Hegeman JG, Heinrich J, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herndon M, Herner K, Hesketh G, Heuser J, Hewamanage S, Hidas D, Hildreth MD, Hill CS, Hirosky R, Hirschbuehl D, Hoang T, Hobbs JD, Hocker A, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hou S, Houlden M, Hsu SC, Hu Y, Hubacek Z, Hughes RE, Hurwitz M, Husemann U, Huske N, Hussein M, Huston J, Hynek V, Iashvili I, Illingworth R, Incandela J, Introzzi G, Iori M, Ito AS, Ivanov A, Jabeen S, Jaffre M, Jain S, James E, Jamin D, Jang D, Jayatilaka B, Jeon EJ, Jesik R, Jha MK, Jindariani S, Johns K, Johnson C, Johnson M, Johnson W, Johnston D, Jonckheere A, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Juste A, Kajfasz E, Kamon T, Karchin PE, Kar D, Karmanov D, Kasper PA, Kato Y, Katsanos I, Kaushik V, Kehoe R, Kephart R, Kermiche S, Ketchum W, Keung J, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim HW, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirby MH, Kirsch L, Kirsch M, Klimenko S, Kohli JM, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kozelov AV, Kraus J, Kreps M, Kroll J, Krop D, Krumnack N, Kruse M, Krutelyov V, Kuhr T, Kulkarni NP, Kumar A, Kupco A, Kurata M, Kurca T, Kuzmin VA, Kvita J, Kwang S, Laasanen AT, Lam D, Lami S, Lammel S, Lammers S, Lancaster M, Lander RL, Landsberg G, Lannon K, Lath A, Latino G, Lazzizzera I, Lebrun P, LeCompte T, Lee E, Lee HS, Lee HS, Lee JS, Lee SW, Lee WM, Leflat A, Lellouch J, Leone S, Lewis JD, Li L, Li QZ, Lietti SM, Lim JK, Linacre J, Lincoln D, Lin CJ, Lindgren M, Linnemann J, Lipaev VV, Lipeles E, Lipton R, Lister A, Litvintsev DO, Liu C, Liu T, Liu Y, Liu Z, Lobodenko A, Lockyer NS, Loginov A, Lokajicek M, Lovas L, Love P, Lubatti HJ, Lucchesi D, Lueck J, Lujan P, Lukens P, Luna-Garcia R, Lungu G, Lyon AL, Lysak R, Lys J, Maciel AKA, Mackin D, MacQueen D, Madrak R, Maeshima K, Magana-Villalba R, Makhoul K, Maksimovic P, Mal PK, Malde S, Malik S, Malik S, Malyshev VL, Manca G, Manousakis-Katsikakis A, Maravin Y, Margaroli F, Marino C, Marino CP, Martin A, Martin V, Martinez M, Martinez-Ballarin R, Martinez-Ortega J, Mastrandrea P, Mathis M, Mattig P, Mattson ME, Mazzanti P, McCarthy R, McFarland KS, McGivern CL, McIntyre P, McNulty R, Mehta A, Mehtala P, Meijer MM, Melnitchouk A, Mendoza L, Menezes D, Menzione A, Mercadante PG, Merkin M, Mesropian C, Meyer A, Meyer J, Miao T, Mietlicki D, Miladinovic N, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Mondal NK, Mondragon MN, Moon CS, Moore R, Morello MJ, Morlock J, Moulik T, Fernandez PM, Muanza GS, Mukherjee A, Mulhearn M, Muller T, Mulmenstadt J, Mundal O, Mundim L, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nagy E, Naimuddin M, Nakamura K, Nakano I, Napier A, Narain M, Nayyar R, Neal HA, Negret JP, Nett J, Neu C, Neubauer MS, Neubauer S, Neustroev P, Nielsen J, Nilsen H, Nodulman L, Nogima H, Norman M, Norniella O, Novaes SF, Nunnemann T, Nurse E, Oakes L, Obrant G, Oh SH, Oh YD, Oksuzian I, Okusawa T, Onoprienko D, Orava R, Orduna J, Osman N, Osta J, Osterberg K, Otec R, Garzon GJY, Owen M, Padilla M, Padley P, Griso SP, Pagliarone C, Palencia E, Pangilinan M, Papadimitriou V, Papaikonomou A, Paramanov AA, Parashar N, Parihar V, Park SJ, Park SK, Parks B, Parsons J, Partridge R, Parua N, Pashapour S, Patrick J, Patwa A, Pauletta G, Paulini M, Paus C, Peiffer T, Pellett DE, Penning B, Penzo A, Perfilov M, Peters K, Peters Y, Petroff P, Phillips TJ, Piacentino G, Pianori E, Piegaia R, Pinera L, Piper J, Pitts K, Plager C, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pol ME, Polozov P, Pondrom L, Popov AV, Potamianos K, Poukhov O, Prewitt M, Price D, Prokoshin F, Pronko A, Protopopescu S, Ptohos F, Pueschel E, Punzi G, Pursley J, Qian J, Quadt A, Quinn B, Rademacker J, Rahaman A, Ramakrishnan V, Rangel MS, Ranjan K, Ranjan N, Ratoff PN, Razumov I, Redondo I, Renkel P, Renton P, Renz M, Rescigno M, Rich P, Richter S, Rijssenbeek M, Rimondi F, Ripp-Baudot I, Ristori L, Rizatdinova F, Robinson S, Robson A, Rodrigo T, Rodriguez T, Rogers E, Rolli S, Rominsky M, Roser R, Rossi M, Rossin R, Roy P, Royon C, Rubinov P, Ruchti R, Ruiz A, Russ J, Rusu V, Rutherford B, Saarikko H, Safonov A, Safronov G, Sajot G, Sakumoto WK, Sanchez-Hernandez A, Sanders MP, Sanghi B, Santi L, Sartori L, Sato K, Savage G, Saveliev V, Savoy-Navarro A, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schlabach P, Schliephake T, Schlobohm S, Schmidt A, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwanenberger C, Schwarz T, Schwienhorst R, Scodellaro L, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Sekaric J, Semenov A, Severini H, Sexton-Kennedy L, Sforza F, Sfyrla A, Shabalina E, Shalhout SZ, Shary V, Shchukin AA, Shears T, Shepard PF, Shimojima M, Shiraishi S, Shivpuri RK, Shochet M, Shon Y, Shreyber I, Simak V, Simonenko A, Sinervo P, Sirotenko V, Sisakyan A, Skubic P, Slattery P, Slaughter AJ, Slaunwhite J, Sliwa K, Smirnov D, Smith JR, Snider FD, Snihur R, Snow GR, Snow J, Snyder S, Soha A, Soldner-Rembold S, Somalwar S, Sonnenschein L, Sopczak A, Sorin V, Sosebee M, Soustruznik K, Spurlock B, Squillacioti P, Stanitzki M, Stark J, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Stolin V, Stoyanova DA, Strandberg J, Strang MA, Strauss E, Strauss M, Strohmer R, Strologas J, Strom D, Strycker GL, Stutte L, Suh JS, Sukhanov A, Suslov I, Svoisky P, Taffard A, Takahashi M, Takashima R, Takeuchi Y, Tanaka R, Tanasijczuk A, Tang J, Taylor W, Tecchio M, Teng PK, Thom J, Thome J, Thompson GA, Thomson E, Tiller B, Tipton P, Titov M, Tkaczyk S, Toback D, Tokar S, Tokmenin VV, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Tsai SY, Tsybychev D, Ttito-Guzman P, Tuchming B, Tu Y, Tully C, Turini N, Tuts PM, Ukegawa F, Unalan R, Uozumi S, Uvarov L, Uvarov S, Uzunyan S, van den Berg PJ, Van Kooten R, van Leeuwen WM, van Remortel N, Varelas N, Varganov A, Varnes EW, Vasilyev IA, Vataga E, Vazquez F, Velev G, Vellidis C, Verdier P, Vertogradov LS, Verzocchi M, Vesterinen M, Vidal M, Vila I, Vilanova D, Vilar R, Vint P, Vogel M, Vokac P, Volobouev I, Volpi G, Wagner P, Wagner RG, Wagner RL, Wagner W, Wagner-Kuhr J, Wahl HD, Wakisaka T, Wallny R, Wang MHLS, Wang SM, Warburton A, Warchol J, Waters D, Watts G, Wayne M, Weber G, Weber M, Weinberger M, Weinelt J, Wester WC, Wetstein M, White A, Whitehouse B, Whiteson D, Wicke D, Wicklund AB, Wicklund E, Wilbur S, Williams G, Williams HH, Williams MRJ, Wilson GW, Wilson P, Wimpenny SJ, Winer BL, Wittich P, Wobisch M, Wolbers S, Wolfe C, Wolfe H, Wood DR, Wright T, Wu X, Wurthwein F, Wyatt TR, Xie Y, Xu C, Yacoob S, Yagil A, Yamada R, Yamamoto K, Yamaoka J, Yang UK, Yang WC, Yang YC, Yao WM, Yasuda T, Yatsunenko YA, Ye Z, Yeh GP, Yi K, Yin H, Yip K, Yoh J, Yoo HD, Yorita K, Yoshida T, Youn SW, Yu GB, Yu I, Yu J, Yu SS, Yun JC, Zanetti A, Zeitnitz C, Zelitch S, Zeng Y, Zhang X, Zhao T, Zheng Y, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zucchelli S, Zutshi V, Zverev EG
Show All Authors

Combination of Tevatron Searches for the Standard Model Higgs Boson in the W+W- Decay Mode

PHYSICAL REVIEW LETTERS 2010 FEB 12; 104(6):? Article 061802
We combine searches by the CDF and D0 Collaborations for a Higgs boson decaying to W+W-. The data correspond to an integrated total luminosity of 4.8 (CDF) and 5.4 (D0) fb(-1) of p (p) over bar collisions at root s = 1.96 TeV at the Fermilab Tevatron collider. No excess is observed above background expectation, and resulting limits on Higgs boson production exclude a standard model Higgs boson in the mass range 162-166 GeV at the 95% C.L.
Radivojac P, Vacic V, Haynes C, Cocklin RR, Mohan A, Heyen JW, Goebl MG, Iakoucheva LM
Show All Authors

Identification, analysis, and prediction of protein ubiquitination sites

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS 2010 FEB 1; 78(2):365-380
Ubiquitination plays an important role in many cellular processes and is implicated in many diseases. Experimental identification of ubiquitination sites is challenging due to rapid turnover of ubiquitinated proteins and the large size of the ubiquitin modifier. We identified 141 new ubiquitination sites using a combination of liquid chromatography, mass spectrometry, and mutant yeast strains. Investigation of the sequence biases and structural preferences around known ubiquitination sites indicated that their properties were similar to those of intrinsically disordered protein regions. Using a combined set of new and previously known ubiquitination sites, we developed a random forest predictor of ubiquitination sites, UbPred. The class-balanced accuracy of UbPred reached 72%, with the area under the ROC curve at 80%. The application of UbPred showed that high confidence Rsp5 ubiquitin ligase substrates and protein with very short half-lives were significantly enriched in the number of predicted ubiquitination sites. Proteome-wide prediction of ubiquitination sites in Saccharomyces cerevisiae indicated that highly ubiquitinated substrates were prevalent among transcription/enzyme regulators and proteins involved in cell cycle control. In the human proteome, cytoskeletal, cell cycle, regulatory, and cancer-associated proteins display higher extent of ubiquitination than proteins from other functional categories. We show that gain and loss of predicted ubiquitination sites may likely represent a molecular mechanism behind a number of disease-associated mutations. UbPred is available at http:// www.ubpred.org. Proteins 2010; 78:365-380. (C) 2009 Wiley-Liss, Inc.
Jones CT, Catanese MT, Law LMJ, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM
Show All Authors

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

NATURE BIOTECHNOLOGY 2010 FEB; 28(2):167-U16
Hepatitis C virus (HCV), which infects 2-3% of the world population, is a causative agent of chronic hepatitis and the leading indication for liver transplantation(1). The ability to propagate HCV in cell culture (HCVcc) is a relatively recent breakthrough and a key tool in the quest for specific antiviral therapeutics. Monitoring HCV infection in culture generally involves bulk population assays, use of genetically modified viruses and/or terminal processing of potentially precious samples. Here we develop a cell-based fluorescent reporter system that allows sensitive distinction of individual HCV-infected cells in live or fixed samples. We demonstrate use of this technology for several previously intractable applications, including live-cell imaging of viral propagation and host response, as well as visualizing infection of primary hepatocyte cultures. Integration of this reporter with modern image-based analysis methods could open new doors for HCV research.
McDermott BM, Asai Y, Baucom JM, Jani SD, Castellanos Y, Gomez G, McClintock JM, Starr CJ, Hudspeth AJ
Show All Authors

Transgenic labeling of hair cells in the zebrafish acousticolateralis system

GENE EXPRESSION PATTERNS 2010 FEB-MAR; 10(2-3):113-118
The zebrafish provides a useful experimental system for investigations of aural development. To permit the controlled expression of transgenes in developing hair cells, we isolated the genomic control regions of the parvalbumin 3a (pvalb3a) and parvalbumin 3b (pvalb3b) genes. Deletion analysis and somatic-cell transgenesis restricted the cis-acting control regions for hair cells to as little as 484 base pairs for pvalb3a and 650 base pairs for pvalb3b. Using both meganuclease-mediated and standard methods, we produced transgenic animals that transmit transgenes through their germ lines. These fish express GFP in hair cells in the inner ear and lateral line. Two stable transgenic lines express GFP prior to hair-bundle formation, so the associated promoter constructs are suitable for manipulating gene expression during bundle development. We additionally identified a transgenic line that offers variable labeling of supporting cells. (c) 2010 Elsevier B.V. All rights reserved.
Trecki J, Brailoiu GC, Unterwald EM
Show All Authors

Localization of CXCR4 in the forebrain of the adult rat

BRAIN RESEARCH 2010 FEB 22; 1315(?):53-62
Chemokines are small secreted proteins that act as chemoattractants, and their role as neuromodulators in the brain has recently been appreciated. CXCL12 is one of the few chemokines found in neurons and expressed constitutively in the central nervous system. Previous data from our laboratory demonstrate the ability of CXCL12 to modulate the behavioral effects of cocaine, and this modulation is dependent on the central site of administration of CXCL12. The present study used single-staining immunohistochemical and dual-staining immunofluorescent methods to deter-mine the localization of the CXCL12 receptor, CXCR4, in the caudate putamen and nucleus accumbens of the adult rat brain. Results demonstrated that individual neurons in both the caudate putamen and lateral shell of the nucleus accumbens express both CXCR4 and D1 dopamine receptors. Immunofluorescent studies showed that CXCR4 was co-expressed with ChAT, a marker for cholinergic neurons, and with GAD C38, a marker for GABAergic neurons, in the caudate putamen and lateral shell of the accumbens. No evidence of CXCR4 was found in the medial shell or core regions of the nucleus accumbens. These data demonstrate that CXCR4 is expressed by subpopulations of cholinergic and GABAergic neurons in the striatum and suggest that CXCR4 is well-positioned to modulate striatal function. (C) 2009 Elsevier B.V. All rights reserved.
Kinoshita N, Berr A, Belin C, Chappuis R, Nishizawa NK, Lopez-Molina L
Show All Authors

Identification of growth insensitive to ABA3 (gia3), a Recessive Mutation Affecting ABA Signaling for the Control of Early Post-Germination Growth in Arabidopsis thaliana

PLANT AND CELL PHYSIOLOGY 2010 FEB; 51(2):239-251
The stress phytohormone ABA inhibits the developmental transition taking the mature embryo in the dry seed towards a young seedling. ABA also induces the accumulation of the basic leucine zipper (bZIP) transcription factor ABA-insensitive 5 (ABI5) which, apart from blocking endosperm rupture, also protects the embryo by stimulating the expression of late embryogenesis abundant (LEA) genes that conferred osmotolerance during seed maturation. It is unknown whether ABA recruits additional embryonic pathways to control early seedling growth and fitness. Here we identify gia3 (growth insensitive to ABA3), a recessive locus in Arabidopsis mediating cotyledon cellular maturation and ABA-dependent repression of cotyledon expansion and greening. Microarray studies showed that expression of the essential mid-embryogenesis gene Maternal Embryo Effect 26 (MEE26) is induced by ABA during early seedling growth in wild-type (WT) or abi5 plants but not in gia3 mutants. However, we also show that the GIA3 locus controls ABA-dependent gene expression responses that partially overlap with those controlled by ABI5. Thus, the gia3 locus identifies an additional arm of ABA signaling, distinct from that controlled by ABI5, which recruits MEE26 expression and maintains cotyledon embryonic identity. Fine mapping localized the gia3 locus within a 1Mb interval of chromosome 3, containing a large DNA insertion of a duplicated region of chromosome 2. It remains unknown at present whether gia3 phenotypes are the result of single or multiple genetic alterations.
Kopp M, Murray CL, Jones CT, Rice CM
Show All Authors

Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein

JOURNAL OF VIROLOGY 2010 FEB 15; 84(4):1666-1673
Hepatitis C virus (HCV) is a liver-tropic pathogen with severe health consequences for infected individuals. Chronic HCV infection can progress to cirrhosis and hepatocellular carcinoma and is a leading indicator for liver transplantation. The HCV core protein is an essential component of the infectious virus particle, but many aspects of its role remain undefined. The C-terminal region of the core protein acts as a signal sequence for the E1 glycoprotein and undergoes dual processing events during infectious virus assembly. The exact C terminus of the mature, virion-associated core protein is not known. Here, we performed genetic analyses to map the essential determinants of the HCV core C-terminal region, as well as to define the minimal length of the protein that can function for infectious virus production in trans.